Stay updated on Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays the updated system revision: v3.5.3, replacing the previous v3.5.2. This reflects a routine platform release rather than a change to study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-05-07T19:14:49.000Z thumbnail image
  2. Check
    20 days ago
    No Change Detected
  3. Check
    28 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T09:40:32.000Z thumbnail image
  4. Check
    49 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:43:38.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; no substantive study content changes are evident.
    Difference
    0.1%
    Check dated 2026-03-11T17:20:52.000Z thumbnail image
  6. Check
    92 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and a notice about government funding was removed along with Revision: v3.4.1. These are administrative updates that do not affect study details or outcomes.
    Difference
    0.5%
    Check dated 2026-02-11T01:59:37.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    A site-wide government funding notice banner was added and the revision tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-03T23:22:27.000Z thumbnail image

Stay in the know with updates to Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.